Oruka Therapeutics CMO Joana Goncalves sells $523,647 in stock
Oruka Therapeutics' Chief Medical Officer, Joana Goncalves, recently sold a significant amount of the company's common stock, totaling $523,647. The shares were sold at prices ranging from $73.8894 to $77.71 per share, as part of a pre-established Rule 10b5-1 trading plan. This sale occurred amidst the company's impressive stock performance, which has risen by 165% over the past year and 144% year-to-date, bringing Oruka's market capitalization to $5.08 billion.
The stock, however, was deemed overvalued according to InvestingPro analysis. In a separate transaction, Goncalves also purchased 7,000 shares of Oruka Therapeutics through the exercise of employee stock options and warrants, acquiring them at prices between $6.84 and $7.80 per share, equivalent to a total value of $51,240.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.